Tumor and red bone marrow dosimetry: comparison of methods for prospective treatment planning in pretargeted radioimmunotherapy

EJNMMI Physics

Table 1 Pa tient and VOI _tumor details and dose results

Pt. #	Age (years)	Gender	Location of VOI _tumor	AA (GBq)	Volume of VOI _tumor (mL)	tox	3D-RD		OLINDA
Pt. #	Age (years)	Gender	Location of VOI _tumor	AA (GBq)	Volume of VOI _tumor (mL)	grade thr - grade leuc	AD _tumor (Gy)	AD _RBM (Gy)	AD _tumor (Gy)
7	63	F	Rectum	6.2	14	0 - 0	0.73	0.39	0.71
10	70	M	Liver	7.4	70	4 - 1	2.94	0.51	2.67
11	55	F	Liver	7.4	44	0 - 0	2.53	0.29	2.47
12	70	M	Liver	7.4	386	0 - 0	1.54	0.30	1.47
13	76	M	Colon	7.4	23	0 - 0	0.51	0.12	0.51
14	52	F	Liver	4.0	23	1 - 0	3.70	0.70	3.72
15	58	M	Liver	5.9	285	1 - 0	0.86	0.58	0.83
16	76	M	Colon	4.6	121	3 - 2	0.66	0.97	0.64
17	73	M	Lung	4.5	65	2 - 0	0.63	0.43	0.62
18	63	F	Liver	2.5	104	0 - 2	4.52	0.47	4.44
19	66	F	Liver	7.4	141	0 - 0	1.45	0.28	1.38
20	72	M	Lung	5.6	723	1 - 0	0.46	0.72	0.45
21	39	F	Liver	5.6	154	0 - 0	2.47	0.23	2.45
Mean	64				166		1.77	0.46	1.72

RBM = red bone marrow. AA = administered activity, Pt. # = patient number, tox = toxicity, grade thr = grade thrombocytopenia, grade leuc = grade leucopenia.